| Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group SF Barrington, NG Mikhaeel, L Kostakoglu, M Meignan, M Hutchings, ... Journal of clinical oncology 32 (27), 3048-3058, 2014 | 1706 | 2014 |
| Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma ME Juweid, S Stroobants, OS Hoekstra, FM Mottaghy, M Dietlein, ... Journal of clinical oncology 25 (5), 571-578, 2007 | 1686 | 2007 |
| Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised … MS Hofman, N Lawrentschuk, RJ Francis, C Tang, I Vela, P Thomas, ... The Lancet 395 (10231), 1208-1216, 2020 | 1574 | 2020 |
| [177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study MS Hofman, J Violet, RJ Hicks, J Ferdinandus, SP Thang, T Akhurst, ... The Lancet Oncology 19 (6), 825-833, 2018 | 1036 | 2018 |
| Delivering affordable cancer care in high-income countries R Sullivan, J Peppercorn, K Sikora, J Zalcberg, NJ Meropol, E Amir, ... The lancet oncology 12 (10), 933-980, 2011 | 826 | 2011 |
| Prognostic Significance of [18F]-Misonidazole Positron Emission Tomography–Detected Tumor Hypoxia in Patients With Advanced Head and Neck Cancer … D Rischin, RJ Hicks, R Fisher, D Binns, J Corry, S Porceddu, LJ Peters Journal of Clinical Oncology 24 (13), 2098-2104, 2006 | 605 | 2006 |
| Somatostatin Receptor Imaging with 68Ga DOTATATE PET/CT: Clinical Utility, Normal Patterns, Pearls, and Pitfalls in Interpretation MS Hofman, WFE Lau, RJ Hicks Radiographics 35 (2), 500-516, 2015 | 534 | 2015 |
| Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non–small-cell … MP Mac Manus, RJ Hicks, JP Matthews, A McKenzie, D Rischin, ... Journal of Clinical Oncology 21 (7), 1285-1292, 2003 | 529 | 2003 |
| Evaluation of circulating tumor cells and circulating tumor DNA in non–small cell lung cancer: Association with clinical endpoints in a phase II clinical trial of pertuzumab … EA Punnoose, S Atwal, W Liu, R Raja, BM Fine, BGM Hughes, RJ Hicks, ... Clinical Cancer Research 18 (8), 2391-2401, 2012 | 517 | 2012 |
| Ibrutinib plus venetoclax for the treatment of mantle-cell lymphoma CS Tam, MA Anderson, C Pott, R Agarwal, S Handunnetti, RJ Hicks, ... New England journal of medicine 378 (13), 1211-1223, 2018 | 443 | 2018 |
| ENETS consensus guidelines for the standards of care in neuroendocrine tumors: radiological, nuclear medicine and hybrid imaging A Sundin, R Arnold, E Baudin, JB Cwikla, B Eriksson, S Fanti, N Fazio, ... Neuroendocrinology 105 (3), 212-244, 2017 | 434 | 2017 |
| MRI-negative PET-positive temporal lobe epilepsy: a distinct surgically remediable syndrome RP Carne, TJ O'brien, CJ Kilpatrick, LR MacGregor, RJ Hicks, MA Murphy, ... Brain 127 (10), 2276-2285, 2004 | 404 | 2004 |
| Dosimetry of 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: correlations between pretherapeutic imaging and whole-body tumor dosimetry with treatment outcomes J Violet, P Jackson, J Ferdinandus, S Sandhu, T Akhurst, A Iravani, ... Journal of Nuclear Medicine 60 (4), 517-523, 2019 | 403 | 2019 |
| 90Y-Edotreotide for Metastatic Carcinoid Refractory to Octreotide DL Bushnell Jr, TM O'Dorisio, MS O'Dorisio, Y Menda, RJ Hicks, ... Journal of Clinical Oncology 28 (10), 1652-1659, 2010 | 391 | 2010 |
| High rate of detection of unsuspected distant metastases by PET in apparent Stage III non–small-cell lung cancer: implications for radical radiation therapy MP Mac Manus, RJ Hicks, JP Matthews, A Hogg, AF McKenzie, A Wirth, ... International Journal of Radiation Oncology* Biology* Physics 50 (2), 287-293, 2001 | 370 | 2001 |
| Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing DM Kurtz, MR Green, SV Bratman, F Scherer, CL Liu, CA Kunder, ... Blood, The Journal of the American Society of Hematology 125 (24), 3679-3687, 2015 | 360 | 2015 |
| Prostate-specific membrane antigen PET: clinical utility in prostate cancer, normal patterns, pearls, and pitfalls MS Hofman, RJ Hicks, T Maurer, M Eiber Radiographics 38 (1), 200-217, 2018 | 355 | 2018 |
| EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT) C Kratochwil, WP Fendler, M Eiber, R Baum, MF Bozkurt, J Czernin, ... European journal of nuclear medicine and molecular imaging 46, 2536-2544, 2019 | 353 | 2019 |
| UV-associated mutations underlie the etiology of MCV-negative Merkel cell carcinomas SQ Wong, K Waldeck, IA Vergara, J Schröder, J Madore, JS Wilmott, ... Cancer research 75 (24), 5228-5234, 2015 | 350 | 2015 |
| European association of nuclear medicine practice guideline/society of nuclear medicine and molecular imaging procedure standard 2019 for radionuclide imaging of … D Taïeb, RJ Hicks, E Hindié, BA Guillet, A Avram, P Ghedini, HJ Timmers, ... European journal of nuclear medicine and molecular imaging 46, 2112-2137, 2019 | 310 | 2019 |
Professor Michael S. HofmanClinician-Scientist, Peter MacCallum Cancer Centre & University of MelbourneE-mail confirmado em petermac.org
